Sonapha SRL
1.3 FTEThe score of Sonapha shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -9 % Total assets -12 % Headcount (avg FTE) +44 %
Accounts of the company itself (not consolidated).
The full file covers 7 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Sonapha's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 29,050 € | ||||
| Equity | 118,797 € | ||||
| Cash | 81,793 € | ||||
| EBITDA | 132,746 € | ||||
| Total assets | 568,273 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Aug 2026
- Year ended 31 Dec 2024filed on 28 Nov 2025
- Year ended 31 Dec 2023filed on 29 Aug 2024
- Year ended 31 Dec 2022filed on 29 Aug 2023
- Year ended 31 Dec 2021filed on 31 Aug 2022
Sonapha's financial analysis
- Solvency20.9%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Sonapha
Sonapha's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0692.989.477
- VAT number
- BE0692989477
- Peppol
- Registered · 0208:0692989477 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 27 Mar 2018
- Registered office
- 6640 Vaux-sur-Sûre
- Size
- Micro · 1.3 FTE
- Latest accounts
- 2025 · filed on 31 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Sonapha (SRL) has been based in Vaux-sur-Sûre since 2018, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 29,050 € and equity of 118,797 €; its revenue is not published. With 1.3 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 20.9%, below the median of its sector (41.5%).
Companies similar to Sonapha
Companies in the same business, of comparable size and area, outside its group.
- Vasseur-Sevrin Retail sale of pharmaceutical products Chastre · balance sheet 567,446 €
- VAN DE Plas Pharma Retail sale of pharmaceutical products Sint-Genesius-Rode · balance sheet 566,351 €
- Apotheek Mattheeuws A. Retail sale of pharmaceutical products Bruges · balance sheet 570,397 €
- Pharmacie Cawet - Swalue Retail sale of pharmaceutical products Chimay · balance sheet 565,492 €
- Infiphar Retail sale of pharmaceutical products Tienen · balance sheet 565,355 €
- Apoteek Termote Retail sale of pharmaceutical products Waasmunster · balance sheet 565,154 €
- Pharm@dvice Retail sale of pharmaceutical products Fexhe-le-Haut-Clocher · balance sheet 571,791 €
- Wpauwels Retail sale of pharmaceutical products Bornem · balance sheet 573,062 €
Frequently asked questions about Sonapha
What is the revenue of Sonapha?
Sonapha files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Sonapha?
In Belgium, the VAT number is the company number prefixed with BE: BE0692989477 for Sonapha, if the company is VAT-registered. Its company number (CBE) is 0692.989.477.
Where is the registered office of Sonapha?
According to the CBE register, the registered office of Sonapha is in 6640 Vaux-sur-Sûre.
What is the equity of Sonapha?
At the close of the 2025 financial year, the equity of Sonapha amounts to 118,797 €, a solvency of 20.9% of total assets.
How many people work at Sonapha?
1.3 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Sonapha?
The register lists 2 active mandates at Sonapha. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Sonapha
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →